MKS InstrumentsMKSI
About: MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.
Employees: 10,200
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
1,125% more call options, than puts
Call options by funds: $197M | Put options by funds: $16M
33% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]
33% more repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 124
17% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 52
3.6% more ownership
Funds ownership: 100.86% [Q3] → 104.47% (+3.6%) [Q4]
0% less capital invested
Capital invested by funds: $7.37B [Q3] → $7.34B (-$29.6M) [Q4]
1% less funds holding
Funds holding: 405 [Q3] → 402 (-3) [Q4]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
8 analyst ratings
Benchmark Mark Miller 49% 1-year accuracy 18 / 37 met price target | 31%upside $135 | Buy Maintained | 14 Feb 2025 |
Morgan Stanley Joseph Moore 72% 1-year accuracy 43 / 60 met price target | 43%upside $147 | Overweight Maintained | 14 Feb 2025 |
Needham James Ricchiuti 45% 1-year accuracy 54 / 120 met price target | 41%upside $145 | Buy Maintained | 14 Feb 2025 |
Goldman Sachs Toshiya Hari 60% 1-year accuracy 60 / 100 met price target | 25%upside $129 | Neutral Maintained | 14 Feb 2025 |
Cantor Fitzgerald Matthew Prisco 71% 1-year accuracy 12 / 17 met price target | 36%upside $140 | Overweight Reiterated | 13 Feb 2025 |
Financial journalist opinion
Based on 9 articles about MKSI published over the past 30 days
